Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Cocco

Showing results (111-120 of 267) with videos related to

Pageof 27
Sort By:
Journal of Neurology|May 17, 2025
Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosisElisa Gervasoni, Alessandro Torchio, Rita Bertoni, et al.
Journal of Neurology|May 21, 2024
Moving towards a new era for the treatment of neuromyelitis optica spectrum disordersPaolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Plos One|June 11, 2026
Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure developmentAmbra Mara Giovannetti, Andrea Giordano, Edoardo Donarelli, et al.
Functional Neurology|October 20, 2006
Effect of dose and frequency of interferon beta-1a administration on clinical and magnetic resonance imaging parameters in relapsing-remitting multiple sclerosisEleonora Cocco, Piernicola Marchi, Gianluca Floris, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 2, 2019
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by <sup>1</sup>H-NMR SpectroscopyLorena Lorefice, Federica Murgia, Giuseppe Fenu, et al.
Journal of Neurology|March 7, 2018
Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI studyLorena Lorefice, Giuseppe Fenu, Roberta Pitzalis, et al.
BMC Neurology|May 13, 2018
A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controlsJessica Frau, Giuseppe Fenu, Alessio Signori, et al.
Journal of Neurology|March 26, 2018
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trialGiancarlo Coghe, Federica Corona, Elisabetta Marongiu, et al.
Journal of Neurology|December 12, 2024
Spasticity patterns assessment and recognition for therapeutic approaches (SPARTA) in multiple sclerosis: a multicenter epidemiological studyPaolo De Blasiis, Andrea Massimiani, Cristina Inglese, et al.
Journal of Neuroinflammation|July 15, 2015
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosisCaterina Veroni, Fabiana Marnetto, Letizia Granieri, et al.
Pageof 27

Showing results (111-120 of 267) with videos related to

Sort By:
Pageof 27
Journal of Neurology|May 17, 2025
Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosisElisa Gervasoni, Alessandro Torchio, Rita Bertoni, et al.
Journal of Neurology|May 21, 2024
Moving towards a new era for the treatment of neuromyelitis optica spectrum disordersPaolo Preziosa, Maria Pia Amato, Luca Battistini, et al.
Plos One|June 11, 2026
Quality of life domains revised by people with multiple sclerosis and healthcare professionals for adaptive measure developmentAmbra Mara Giovannetti, Andrea Giordano, Edoardo Donarelli, et al.
Functional Neurology|October 20, 2006
Effect of dose and frequency of interferon beta-1a administration on clinical and magnetic resonance imaging parameters in relapsing-remitting multiple sclerosisEleonora Cocco, Piernicola Marchi, Gianluca Floris, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 2, 2019
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by <sup>1</sup>H-NMR SpectroscopyLorena Lorefice, Federica Murgia, Giuseppe Fenu, et al.
Journal of Neurology|March 7, 2018
Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI studyLorena Lorefice, Giuseppe Fenu, Roberta Pitzalis, et al.
BMC Neurology|May 13, 2018
A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controlsJessica Frau, Giuseppe Fenu, Alessio Signori, et al.
Journal of Neurology|March 26, 2018
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trialGiancarlo Coghe, Federica Corona, Elisabetta Marongiu, et al.
Journal of Neurology|December 12, 2024
Spasticity patterns assessment and recognition for therapeutic approaches (SPARTA) in multiple sclerosis: a multicenter epidemiological studyPaolo De Blasiis, Andrea Massimiani, Cristina Inglese, et al.
Journal of Neuroinflammation|July 15, 2015
Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosisCaterina Veroni, Fabiana Marnetto, Letizia Granieri, et al.
Pageof 27